Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2025-12-25 @ 9:00 PM
NCT ID:
NCT00365456
Pre Assignment Details:
* Period I: total number of 405 patients were included and all received PTH(1-84) treatment for 1 year
* Period II: of those 405 patients, 282 continued into the 2. year and all received risedronate
* Period III: during the 3. year, the remaining 268 patients were randomised to either PTH(1-84) (=136 patients) or risedronate (=132 patients)
Recruitment Details:
The trial was divided into 3 consecutive open-label treatment phases of 12 months with randomisation after Trial Period II.
From 407 enrolled patients in total, 2 patients were enrolled but were never exposed to trial treatment. Thus, 405 patients in total received trial treatment.
Study:
NCT00365456
Study Brief:
Results Section:
NCT00365456